Schizophrenia: all 3,539 studies
Page 22 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.
- Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic AbnormalitiesCompletedNCT02751307Phase 4
- Efficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize...CompletedNCT02748486Not applicable
- Transcranial Direct Current Stimulation (tDCS) as a Treatment for Cognitive Deficits in SchizophrenicCompletedNCT02748083Not applicable
- Magnetic Seizure Therapy for SchizophreniaTerminatedNCT02746965Not applicable
- Validation of a Clinical Screening Grid for Syndromic SchizophreniaTerminatedNCT02746510Not applicable
- STIM'ZO : Examining tDCS as an add-on Treatment for Persistent Symptoms in SchizophreniaCompletedNCT02744989Not applicable
- Long-Term Exercise Training Therapy Versus Usual Care in Patients With SchizophreniaCompletedNCT02743143Not applicable
- Motivation and Executive Control in SchizophreniaCompletedNCT02734927Not applicable
- Validation of a Scale to Evaluate the Perception of Oral Health in Patients With SchizophreniaCompletedNCT02730832Not applicable
- Safety, Tolerability, and Pharmacokinetics of APN1125 in Subjects With SchizophreniaSuspendedNCT02724917Phase 1/2
- A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With SchizophreniaCompletedNCT02720263Phase 1
- Psychoeducation for Vietnamese Families With a Patient With SchizophreniaCompletedNCT02715349Not applicable
- Disorder-tailored Transcranial Direct Current Stimulation (tDCS) of the Prefrontal CortexStatus unknownNCT02715128Not applicable
- Response to Clozapine in Treatment Resistant Schizophrenia: A Longitudinal Magnetic Resonance Spectroscopy StudyStatus unknownNCT02714894
- A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month FormulationCompletedNCT02713282Phase 3
- A Study to Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With AntipsychoticsCompletedNCT02712463
- Virtual Rehabilitation for the Treatment of Motivational Deficits in SchizophreniaCompletedNCT02709733Not applicable
- The Gut Metagenome Research of SchizophreniaStatus unknownNCT02708316
- Olanzapine vs. Low-dose Olanzapine Plus TrifluoperazineCompletedNCT02704962Phase 4
- Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in SchCompletedNCT02697045Phase 4
- PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With SchizophreniaCompletedNCT02687984Phase 1
- Carnosine and Cognitive Training in SchizophreniaCompletedNCT02686697Phase 2/3
- Multi-center Imaging Genetics Studies in ChinaStatus unknownNCT02681822
- Efficacy of ISST in SchizophreniaCompletedNCT02678858Not applicable
- Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) AntagonismCompletedNCT02675530Phase 1
- Treatment of Auditory Hallucinations in Schizophrenia With Bilateral Theta Burst StimulationCompletedNCT02670291Not applicable
- Efficiency of the French Translation Social Cognition and Interactive Training (SCIT)ProgramCompletedNCT02667834Not applicable
- Remote Monitoring and Support for Patients With Schizophrenia, Schizoaffective or Bipolar Disorder on AdherenceStatus unknownNCT02665611Not applicable
- Video as a Tool to Improve Insight in SchizophreniaCompletedNCT02664129Not applicable
- Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for DepressionCompletedNCT02661789Not applicable
- Transcranial Direct Current Stimulation for Hallucinations in First-Episode SchizophreniaWithdrawnNCT02661347Not applicable
- Social Cognitive Assessment in Autism and SchizophreniaCompletedNCT02660775Not applicable
- Early and Short Psycho-educational Lifestyle InterventionTerminatedNCT02657941Not applicable
- Have a Good Grasp of the Worldthe WorldCompletedNCT02655172Not applicable
- Sodium Butyrate For Improving Cognitive Function In SchizophreniaWithdrawnNCT02654405Phase 2/3
- Effects of Noninvasive Brain Stimulation Techniques on BDNF LevelsTerminatedNCT02652832Not applicable
- The Role of miR-30 Family Dysregulation in Response to Antipsychotic TreatmentStatus unknownNCT02650102Phase 1/2
- Switching Antipsychotics: Abrupt Discontinuation Versus OverlapCompletedNCT02640300Phase 4
- A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective DisorderCompletedNCT02636842Phase 1
- Perception of Facial Emotions in Schizophrenia and 22q11 Deletion SyndromeCompletedNCT02634671Not applicable
- Joint Crisis Plan Effectiveness in Preventing Relapses in Schizophrenia and Schizoaffective DisorderCompletedNCT02627716Not applicable
- Regulation of Arginine-vasopressin (AVP)CompletedNCT02626832Not applicable
- The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring.CompletedNCT02625103Phase 4
- A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic SchizophreniaCompletedNCT02624167Phase 2
- Understanding and Helping Families: Parents With PsychosisStatus unknownNCT02622048Not applicable
- Target Engagement of the Early Auditory Processing Network by Transcranial Direct Current Stimulation (tDCS)CompletedNCT02620267Not applicable
- NRX-1074 in Early Course SchizophreniaWithdrawnNCT02603458Phase 2
- Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)CompletedNCT02600741
- Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental IllnessCompletedNCT02594696Not applicable
- Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in GhanaCompletedNCT02593734Phase 4
- Positive Emotions Program for Schizophrenia (PEPS)CompletedNCT02593058Not applicable
- Computerized Cognitive Training for Schizophrenia in BrazilStatus unknownNCT02591498Phase 3
- Safety, Blood Levels and Effects of AUT00206CompletedNCT02589262Phase 1
- The Neural Bases of Early Visual and Auditory Processing and Emotion Recognition Deficits in SchizophreniaStatus unknownNCT02588014
- Antipsychotics and Risk of Hyperglycemic EmergenciesCompletedNCT02582736
- Adult Oxytocin StudyCompletedNCT02577575Early Phase 1
- Modified Psychodynamic Psychotherapy for Patients With SchizophreniaCompletedNCT02576613Not applicable
- Gender Differences in Social Cognition in Patients With Schizophrenia of Recent Diagnosis and Healthy Controls SubjectsCompletedNCT02575209
- Guideline vs Usual Treatment in Schizophrenic AdolescentsCompletedNCT02573701Not applicable
- Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment With AntipsychoticsCompletedNCT02573168Not applicable
- Autobiographical Memory Organization in SchizophreniaCompletedNCT02570594Not applicable
- Oxytocin MEG StudyCompletedNCT02568709Early Phase 1
- Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581CompletedNCT02567370Phase 1
- Adult Study Oxytocin - BehavioralCompletedNCT02567032Early Phase 1
- Adult Study Oxytocin - fMRICompletedNCT02566356Early Phase 1
- Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase PsychosisCompletedNCT02566057Not applicable
- the Phenotypic and Genetic Profile of Patients With Early Onset Schizophrenia Associated With Autism Spectrum Disorder.CompletedNCT02565524Not applicable
- The Influence of Omega-3 Fatty Acid on the Violence of Schizophrenia Patient and the Possible MechanismStatus unknownNCT02552758Not applicable
- Influence of Emotion in a Test Run ForgetfulnessCompletedNCT02547259Not applicable
- Upside Down, Give me the HandleCompletedNCT02544516Not applicable
- Can we Forget? Directed Forgetting and Embodied Cognition in SchizophreniaCompletedNCT02538445Not applicable
- Nicotinic Receptors and SchizophreniaWithdrawnNCT02538081Phase 1/2
- Schizophrenia TreAtment With electRic Transcranial StimulationCompletedNCT02535676Phase 3
- Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-upCompletedNCT02534363Phase 4
- Minocycline Augmentation of Clozapine for Treatment Resistant SchizophreniaStatus unknownNCT02533232Phase 1
- Non-Interventional Study of Participants With Newly Diagnosed Schizophrenia Treated With Paliperidone PalmitateCompletedNCT02532842
- DAAOI-2 add-on Treatment for Treatment-resistant SchizophreniaCompletedNCT02532686Phase 2
- Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-upStatus unknownNCT02532491Phase 4
- Evaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic SymptomsStatus unknownNCT02529163Not applicable
- Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-upCompletedNCT02526030Phase 4
- Interest of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Auditory HallucinationsCompletedNCT02525315Phase 2
- Assessing the Impact of Self-directed Care, Within a Medicaid-funded Environment,on Participation and Community LivingCompletedNCT02520024Not applicable
- Evaluate the Efficacy of a Global Dental Health Promotion Program on Dental Hygiene in Patients With Schizophrenia.TerminatedNCT02512367Not applicable
- Bifrontal and Bitemporal Electroconvulsive Therapy (ECT) in Treatment of Patients With SchizophreniaStatus unknownNCT02511509Not applicable
- Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteineCompletedNCT02505477Phase 4
- Role Functioning Changes NOSTerminatedNCT02505022
- Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or SchizoaffectiveCompletedNCT02504476Phase 1
- Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy VolunteersCompletedNCT02501109Phase 1
- Prepulse Inhibition (PPI) of Startle Reflex in Schizophrenia Patients Related to Type of Treatment and Illness DurationCompletedNCT02484521Not applicable
- Treating Social Cognition With Theta Burst Stimulation: a Multicentric StudyStatus unknownNCT02479919Not applicable
- A Trial of Cognitive Training in SchizophreniaCompletedNCT02478827Not applicable
- A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance AbuseCompletedNCT02476877
- A Pilot Trial of Curcumin Effects on Cognition in SchizophreniaTerminatedNCT02476708Not applicable
- Self-Management and Recovery Technology Psychosocial Intervention TrialCompletedNCT02474524Not applicable
- Niacin Skin Flush Response in Patients With SchizophreniaCompletedNCT02458924Phase 2/3
- Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With SchizophreniaStatus unknownNCT02453893Phase 3
- In Vivo Imaging of Therapeutic Electric Current FlowCompletedNCT02453763
- The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled TrialCompletedNCT02453217Not applicable
- Treatment of Refractory Auditory Verbal Hallucinations With tDCS in SchizophreniaCompletedNCT02451371Phase 1/2
- Study of Immunotherapy in Autoantibody Positive PsychosisCompletedNCT02449746Not applicable